IntegraGen In Brief This Week: MDxHealth, Agilent Technologies, IsoPlexis, IntegraGen, More News items for the week of Jan. 9, 2023. OncoDNA to Widen Cancer Analytics Offering, Biopharma Reach With IntegraGen Acquisition Premium Belgium's OncoDNA believes that IntegraGen's bioinformatics platform will help it manage more cancer patient data and quickly generate patient-specific treatment reports for clinicians. OncoDNA to Acquire IntegraGen for €14.5M Belgium-based OncoDNA will purch IntegraGen Receives CE Mark, Installs Software at Dana-Farber Cancer Institute Premium The French bioinformatics and genomic services company will help Dana-Farber manage French Medical Genomics Initiative's Pilot Sequencing Platforms Set to Commence Operations Premium The launch of the sequencing platforms is a milestone for the Plan France Médecine Génomique 2025, a €670 million initiative the French government announced two years ago. Jan 10, 2018 GoPath Labs to Commercialize IntegraGen Cancer Therapy Biomarker Test Sep 7, 2017 IntegraGen Theranostic Test for Colorectal Cancer Gets CE-IVD Mark Mar 8, 2017 IntegraGen, Laboratoire Cerba Ink Cancer Biomarker Deal Jul 1, 2016 Paris University Hospitals, IntegraGen Partner to Develop Sequencing Platform Dec 2, 2015 IntegraGen Partners With FIRE-3 Researchers to Study microRNA Cancer Biomarker Jul 9, 2015 IntegraGen, Pompidou Hospital to Develop Sequencing Methods Mar 24, 2015 IntegraGen to Provide High-throughput Sequencing for Institut Pasteur Feb 5, 2015 Genoma to Commercialize IntegraGen ASD Test Dec 16, 2014 IntegraGen, PICCOLO Researchers Collaborate to Validate Metastatic Colorectal Cancer Biomarker Dec 8, 2014 IntegraGen Nets Exclusive Rights to Liver Cancer Gene Signatures Sep 3, 2014 IntegraGen, IFCT to Evaluate microRNA as Lung Cancer Biomarker Jun 23, 2014 French Consortium Launches Clinical Exome Interpretation Project for Cancer Patients Apr 23, 2014 Gustave Roussy, IntegraGen Partner to Support Clinical Cancer Trials with Exome, RNA Sequencing Premium Mar 24, 2014 IntegraGen, Gustave Roussy Create Clinical Sequencing Unit Jan 14, 2014 IntegraGen Partners with CRUK to Validate miRNA Marker for Colorectal Cancer Drug Response Oct 17, 2013 IntegraGen Prepping miRNA-based Colorectal Cancer Assay for CE Mark; Exploring CLIA Options for US Premium Oct 17, 2013 After Licensing microRNA IP, IntegraGen Aims to Launch Cancer Diagnostic in '14 Premium Oct 14, 2013 IntegraGen Acquires Exclusive License to Metastatic Colon Cancer Biomarker Feb 28, 2013 Lab21, IntegraGen to Develop PCR-Based Assay to Guide Colorectal Cancer Therapy Premium Feb 28, 2013 Lab21 to Develop microRNA-Based Colorectal Cancer Diagnostic for IntegraGen Premium Load More Breaking News GA4GH Announces 10 New 'Driver' Projects, Including First Pediatric Partner Single-Cell MRD Assay Helps Characterize Cells Surviving Acute Myeloid Leukemia Therapy Research Triangle Institute Partners With GeneDx, Illumina for Expanded Newborn Screening Study Bionano Genomics' Third Chinese OEM Partner Gets NMPA Nod for Sample Prep Product InformedDNA Buys gWell Health, Names New CEO The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.